The global Allergy Immunotherapy Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 9.5% during the review period (2022 to 2027)
Allergy Immunotherapy Market Overview
Allergy immunotherapy is an adaptive therapy for diseases which is effective during the treatment of allergic conjunctivitis, peanuts allergy, allergic asthma, cat allergy, stinging insect hypersensitivity, etc. Immunotherapy is a treatment for prevention of several allergic reactions like house dust mites, grass pollens, and bee venom. Immunotherapy is growing the dosages of the substance in which the person is allergic over some time. Rise in the allergens causes the immune system to lower the sensitivity to the substance by causing the production of an antibody that will reduce the symptoms of allergy when the person comes in contact with the substance in the future. Immunotherapy is also used to reduce the inflammation of diseases like rhinitis and asthma. Earlier initiating the treatment, the immunology physician and patient identify all the trigger factors for allergy symptoms. Several skin and blood tests are performed for the confirmation of specific antigens to which the person has antibodies. Immunotherapy is usually commended only and only if the person seems to be selectively sensitive to several allergens. After the launches of various new sublingual immuno-therapies in developing countries and the influence of several major players in the allergen immunotherapy market, an increase in an unmet need for novel targeted drugs which can be used to treat the disease conditions are the major factors driving the market. Sublingual allergy immunotherapy has now been clinically proven a more efficient treatment with lesser side effects as compared to alternatives available in the market currently. There is also a change observed in demographics concerning population and macroeconomic climate are other factors driving towards allergy immunotherapy market.
In June 2018, Aimmune Therapeutics, declared phase 3 trial results for AR101, an oral immunotherapy medication focused on peanut allergies, have met all the end points required by the U.S. Food and Drug Administration (FDA)
October 2020, ALK made its once-daily ITULATEK™, which is a standardized allergen extract-based white birch sublingual tablet used in the treatment of tree pollen allergy, available through prescription to patients in Canada.
July 2019, Stallergenes Greer, inked a research collaboration deal with Alyatec, a well-known French contract research organization, to advance its precision medicine in allergy immunotherapy and to proliferate its allergy pathophysiology and endotype knowledge.
What are the major Applications, Types and Regions?
By Type, it is segmented into
By Applications it is segmented into
Allergy Immunotherapy Market Regional Analysis
The United States is probable to be the largest allergy immunotherapy market across the world. High prevalence of allergies and stringent regulatory guidelines that mandate allergic testing in all cases of intensive and emergency care are some of the factors contributing to the progress of the US allergy immunotherapy market. It is estimated that one among every six Americans (around 50 million) suffers from some form of allergy, and around 25 million Americans suffer from respiratory allergies, according to the facts (2018) of Asthma and Allergy Foundation.
Rest of Europe
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
What is our Allergy Immunotherapy Market Report Scope?
Forecast Period 2022 to 2027 CAGR
CAGR of 9.5% during the review period (2022 to 2027).
ALK-Abello,Stallergenes Greer,Merck,Allergy Therapeutics,HAL,Holister Stier,Leti and others
Rest of the World
Rest of Europe
Rest of Asia-Pacific
Middle East & Africa
2017 to 2021
2022 to 2027
Number of Pages
Yes, the report can be customized as per your needs
Key Takeaways from this Allergy Immunotherapy Report
Evaluate Allergy Immunotherapy market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
Analyze the sales and distribution channels across geographies to enhance top-line revenues.
Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the Allergy Immunotherapy market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
What is the study period of this market?
The Allergy Immunotherapy Market is studied from 2017 - 2027.
What is the growth rate of Allergy Immunotherapy Market?
The Allergy Immunotherapy Market is growing at a CAGR of 9.5% over the next 5 years.
What regions does this Allergy Immunotherapy Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SUBJECT MATTER EXPERT ADVICE
GLOBAL ALLERGY IMMUNOTHERAPY MARKETBY TYPES
GLOBAL ALLERGY IMMUNOTHERAPY MARKET BY APPLICATIONS
INCREASING DEMAND FOR ALLERGY IMMUNOTHERAPY
STRINGENT ENVIRONMENTAL REGUALTIONS
HIGH COST ON MATERIALS
ALLERGY IMMUNOTHERAPY GROWTH
APPLICATION OF ALLERGY IMMUNOTHERAPY
IMPACT OF COVID 19
GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES
GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.